Across TCGA pan-cancer cohorts, PRR30 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of PRR30’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where PRR30 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types PRR30 is over-expressed in tumor.

THCA are the cancer types where PRR30 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in PRR30 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	Male	All	+0.018	.003	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: PRR30 RNA expression & survival · all PRR30 data types